394 related articles for article (PubMed ID: 31018110)
21. Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease.
Klymenko V; González Martínez OG; Zarbin M
Stem Cells Transl Med; 2024 Apr; 13(4):317-331. PubMed ID: 38394392
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Age-Related Macular Degeneration with Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
Vitillo L; Tovell VE; Coffey P
Curr Eye Res; 2020 Mar; 45(3):361-371. PubMed ID: 31777296
[TBL] [Abstract][Full Text] [Related]
23. Modeling retinitis pigmentosa through patient-derived retinal organoids.
Li YP; Deng WL; Jin ZB
STAR Protoc; 2021 Jun; 2(2):100438. PubMed ID: 33899019
[TBL] [Abstract][Full Text] [Related]
24. Stem cells for investigation and treatment of inherited retinal disease.
Tucker BA; Mullins RF; Stone EM
Hum Mol Genet; 2014 Sep; 23(R1):R9-R16. PubMed ID: 24647603
[TBL] [Abstract][Full Text] [Related]
25. Bringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology.
Sun S; Li Z; Glencer P; Cai B; Zhang X; Yang J; Li X
Stem Cell Res Ther; 2017 Jun; 8(1):135. PubMed ID: 28583181
[TBL] [Abstract][Full Text] [Related]
26. Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy.
Sinha D; Steyer B; Shahi PK; Mueller KP; Valiauga R; Edwards KL; Bacig C; Steltzer SS; Srinivasan S; Abdeen A; Cory E; Periyasamy V; Siahpirani AF; Stone EM; Tucker BA; Roy S; Pattnaik BR; Saha K; Gamm DM
Am J Hum Genet; 2020 Aug; 107(2):278-292. PubMed ID: 32707085
[TBL] [Abstract][Full Text] [Related]
27. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
Singh MS; MacLaren RE
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
[No Abstract] [Full Text] [Related]
28. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.
Li Y; Tsai YT; Hsu CW; Erol D; Yang J; Wu WH; Davis RJ; Egli D; Tsang SH
Mol Med; 2012 Dec; 18(1):1312-9. PubMed ID: 22895806
[TBL] [Abstract][Full Text] [Related]
29. Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease.
Klymenko V; González Martínez OG; Zarbin MA
Stem Cells Transl Med; 2024 Apr; 13(4):332-345. PubMed ID: 38417110
[TBL] [Abstract][Full Text] [Related]
30. Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration.
Yang YP; Hsiao YJ; Chang KJ; Foustine S; Ko YL; Tsai YC; Tai HY; Ko YC; Chiou SH; Lin TC; Chen SJ; Chien Y; Hwang DK
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430270
[TBL] [Abstract][Full Text] [Related]
31. Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.
Deng WL; Gao ML; Lei XL; Lv JN; Zhao H; He KW; Xia XX; Li LY; Chen YC; Li YP; Pan D; Xue T; Jin ZB
Stem Cell Reports; 2018 Apr; 10(4):1267-1281. PubMed ID: 29526738
[TBL] [Abstract][Full Text] [Related]
32. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
[TBL] [Abstract][Full Text] [Related]
33. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
Ben M'Barek K; Habeler W; Monville C
Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
Croze RH; Clegg DO
Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
[TBL] [Abstract][Full Text] [Related]
35. Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies.
Liu W; Liu S; Li P; Yao K
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563274
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
37. Retinoid Processing in Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cultures.
Fields MA; Bowrey HE; Gong J; Ablonczy Z; Del Priore LV
Prog Mol Biol Transl Sci; 2015; 134():477-90. PubMed ID: 26310172
[TBL] [Abstract][Full Text] [Related]
38. Retinal stem cell transplantation: Balancing safety and potential.
Singh MS; Park SS; Albini TA; Canto-Soler MV; Klassen H; MacLaren RE; Takahashi M; Nagiel A; Schwartz SD; Bharti K
Prog Retin Eye Res; 2020 Mar; 75():100779. PubMed ID: 31494256
[TBL] [Abstract][Full Text] [Related]
39. Stemming retinal regeneration with pluripotent stem cells.
Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M
Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340
[TBL] [Abstract][Full Text] [Related]
40. Stem cell transplantation as a progressing treatment for retinitis pigmentosa.
Hosseini Shabanan S; Seyedmirzaei H; Barnea A; Hanaei S; Rezaei N
Cell Tissue Res; 2022 Feb; 387(2):177-205. PubMed ID: 35001210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
